- Home
- SQNS vs VRCA Comparison
SQNS vs VRCA Comparison
Compare SQNS & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SQNS
- VRCA
- Stock Information
- Founded
- SQNS 2003
- VRCA 2013
- Country
- SQNS France
- VRCA United States
- Employees
- SQNS N/A
- VRCA N/A
- Industry
- SQNS Semiconductors
- VRCA Biotechnology: Pharmaceutical Preparations
- Sector
- SQNS Technology
- VRCA Health Care
- Exchange
- SQNS Nasdaq
- VRCA Nasdaq
- Market Cap
- SQNS 70.9M
- VRCA 58.0M
- IPO Year
- SQNS 2011
- VRCA 2018
- Fundamental
- Price
- SQNS $3.01
- VRCA $0.68
- Analyst Decision
- SQNS Strong Buy
- VRCA Hold
- Analyst Count
- SQNS 1
- VRCA 5
- Target Price
- SQNS $7.50
- VRCA $6.00
- AVG Volume (30 Days)
- SQNS 160.7K
- VRCA 630.2K
- Earning Date
- SQNS 03-06-2025
- VRCA 02-27-2025
- Dividend Yield
- SQNS N/A
- VRCA N/A
- EPS Growth
- SQNS N/A
- VRCA N/A
- EPS
- SQNS 1.65
- VRCA N/A
- Revenue
- SQNS $30,555,000.00
- VRCA $9,210,000.00
- Revenue This Year
- SQNS $10.14
- VRCA $64.32
- Revenue Next Year
- SQNS $8.54
- VRCA $83.90
- P/E Ratio
- SQNS $1.82
- VRCA N/A
- Revenue Growth
- SQNS N/A
- VRCA 187.45
- 52 Week Low
- SQNS $0.85
- VRCA $0.61
- 52 Week High
- SQNS $7.43
- VRCA $11.41
- Technical
- Relative Strength Index (RSI)
- SQNS 45.99
- VRCA 41.77
- Support Level
- SQNS $2.81
- VRCA $0.62
- Resistance Level
- SQNS $3.21
- VRCA $0.76
- Average True Range (ATR)
- SQNS 0.25
- VRCA 0.06
- MACD
- SQNS -0.06
- VRCA 0.01
- Stochastic Oscillator
- SQNS 24.69
- VRCA 40.93
About SQNS Sequans Communications S.A.
Sequans Communications SA is a designer, developer, and supplier of cellular semiconductor solutions for broadband Internet of Things (IoT) markets. Its solutions incorporate baseband processor and radio frequency, transceiver integrated circuits, along with its proprietary signal processing techniques, algorithms, and software stacks. The company's solutions serve as the core wireless broadband communications platform in devices, including smartphones, USB dongles, portable routers, laptops, netbooks, tablets, and other consumer multimedia and industrial devices. Its geographical segments are Taiwan, Korea, China (including Hong Kong), the Rest of Asia, the United States and the Rest of the world.
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.